FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

1078511000001103: Erythromycin 2% / Isotretinoin 0.05% gel 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22632301000001118 Erythromycin 2% / Isotretinoin 0.05% gel 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60126301000001118 Isotretinoin 0.05% / Erythromycin 2% gel 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Is pack of Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has active ingredient Isotretinoin false Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has VMP Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has specific active ingredient Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has specific active ingredient Isotretinoin true Inferred relationship Existential restriction modifier
Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Isotrexin gel (Stiefel Laboratories Ltd) 30 gram Is a True Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Inferred relationship Existential restriction modifier
Isotrexin gel (Mawdsley-Brooks & Company Ltd) 30 gram Is a True Erythromycin 2% / Isotretinoin 0.05% gel 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start